with consistent scoring practices for measuring depressive symptoms for research but may need to have scoring thresholds adjusted for screening purposes in select primary care settings to achieve adequate predictive values for a depressive disorder (Zich, Attkisson, & Greenfield, 1990) . When there is this type of ''utility incongruence'' in the applicability and usefulness of depression measures used for research versus clinical purposes, it can make the translation of research findings into clinical practice even more challenging.
At least two of these depression measures are considered both valid and reliable for the measurement of depressive symptoms in the general population, have repeatedly demonstrated positive predictive values suitable for screening individuals in clinical settings (Watnick, Wang, Demadura, & Ganzini, 2005) , and are used widely in studies to measure depression. These include the BDI-II (Beck et al., 1996) and the PHQ-9 (Kroenke et al., 2001) . The BDI-II is a widely used measure of depressive symptoms. Composed of 21 items, the BDI-II yields a single score with a range of 0 to 63. Standardized score ranges for categorical levels of depressive symptoms are as follows: 0Y13 = minimal, 14Y19 = mild, 20Y28 = moderate, and 29Y63 = severe. Items in the BDI-II were developed to reflect cognitive (C), affective (A), and somatic (S) components of depression (Beck et al., 1996) and to map closely onto the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for a major depressive episode (American Psychiatric Association, 2000) . In methodological studies with diverse populations including African Americans (Gary & Yarandi, 2004; Grothe et al., 2005) , predominantly Caucasian Canadian college students (Beck et al., 1996) , chemically dependent inpatients (Buckley, Parker, & Heggie, 2001) , and depressed geriatric outpatients (Steer, Rissmiller, & Beck, 2000) , the BDI-II factor structure generally reflects these three intended domains within two factors; however, findings have varied, with more recent studies pointing to a more complex, as opposed to simple, two-factor structure (Kneipp, Kairalla, Stacciarini, & Pereira, 2009; Thombs, Ziegelstein, Beck, & Pilote, 2008; Ward, 2006) .
The PHQ-9 is a 10-item self-report questionnaire used to screen for depression using DSM-IV criteria. Items 1 through 9 are used to calculate a symptom severity measure, with a range of 0 to 27 (Kroenke et al., 2001) . Item 10 assesses the extent to which depressive symptoms interfere with dayto-day functioning and can assist clinicians in determining whether symptoms meet the DSM-IV criteria for MDD but is not included in the symptom severity score. Score ranges for categorizing levels of depressive symptoms are as follows: 0Y4 = minimal, 5Y9 = mild, 10Y14 = moderate, 15Y19 = moderately severe, and 20Y27 = severe. The PHQ-9 has emerged consistently as a one-factor structure on the basis of factor analysis findings across diverse populations, including substance abusers (Dum, Pickren, Sobell, & Sobell, 2008) , African Americans, Chinese Americans, Latinos, and Caucasians (Huang, Chung, Kroenke, Delucchi, & Spitzer, 2006) . Convergent validity of the PHQ-9 has been demonstrated in primary care settings (Martin, Rief, Klaiberg, & Braehler, 2006) , dialysis patients (Watnick et al., 2005) , substance abusers (Dum et al., 2008) , patients with depression (Lee, Schulberg, Raue, & Kroenke, 2007) , and Nigerian university students (Adewuya, Ola, & Afolabi, 2006) .
Only four studies were found directly comparing measurement characteristics of the BDI-II and PHQ-9 (Dbouk, Arguedas, & Sheikh, 2008; Dum et al., 2008; Hepner, Hunter, Edelen, Zhou, & Watkins, 2009; Watnick et al., 2005) . Among these, Watnick et al. (2005) found that both the BDI-II and the PHQ-9 demonstrated acceptable degrees of clinical validity on the basis of receiver operator characteristic curves using the Structured Clinical Interview for DSM Disorders -Depression as the gold standard. The remaining three studies demonstrated a high degree of convergent validity between BDI-II and PHQ-9 symptom severity scores, with correlations ranging between .76 and .84. Two of these studies were conducted among substance abusing populations (Dum et al., 2008; Hepner et al., 2009) , one was in a sample of dialysis patients (Watnick et al., 2005) , and the last was in a sample of hepatitis C patients (Dbouk et al., 2008) . All of these studies were conducted in predominantly male or Caucasian samples, and only one reported on socioeconomic status whereby the mean years of education in the sample was 13.8 (Dum et al., 2008) . Overall, these findings are of limited use to health disparities researchers interested in measuring depressive symptoms among predominantly low-income, predominantly female, and/or predominantly minority populations.
Study Purpose
Given the burgeoning interest in health disparities research that focuses on depression either as an outcome or as a mediating or moderating variable, and the inability to generalize existing measurement comparison findings to this population, we sought to compare key aspects of these measures in ways that are meaningful to both clinicians and scientists given the data available from an ongoing randomized controlled trial (RCT). Specifically, the aims of this study were to (a) compare convergent and divergent validity of the BDI-II and the PHQ-9 among low-income women, (b) to examine whether demographic and other health-related factors predict differences in the standardized symptom severity scores of these two measures, and (c) to examine the extent to which BDI-II and PHQ-9 categorical symptom severity classifications were similar within subjects.
Theoretical Framework
Given the aims of this work focus on measurement, psychometric theory provides a guide for the analyses presented here. Concern over the development of psychological measuresVand thus the origin of psychometric theoryV has been traced back to the early 1900s (Strauss & Smith, 2009 ). Broadly conceived, psychometric theory addresses the measurement and quantification of psychological constructs. These constructs take the form of variables in studies conducted routinely in the social and health sciences, and ultimately, the soundness of scientific knowledge claims rests upon the use of valid and reliable measures to represent them. As a major component of psychometric theory, the core principles of construct validation were first proposed by Cronbach and Meehl (1955) and extended to the multitrait-multimethod methodology by Campbell and Fiske (1959) . The most recent version of the Standards for Educational and Psychological Testing (American Educational Research Association, American Psychological Association, & National Council on Measurement in Education, 1999) also regarded construct validity as the most important consideration in test use and interpretation and continue to emphasize the focus of theory and theory testing in construct validation. Campbell and Fiske's (1959) early efforts defined a means for using convergent and divergent validity analyses within a multitrait-multimethod matrix (MTMM) methodology (Strauss & Smith, 2009 ), which allows for partitioning covariance between measures into ''method'' covariance (e.g., dependent on data collection approach such as written questionnaire or interview) and ''trait'' or construct covariance (e.g., dependent solely on construct attributes) (DeVellis, 1991) . Since that time, construct validation methods using the MTMM methodology have advanced through the application of structural equation modeling. The basic premise of MTMM methodology remains a standard approach for instrument development, as does the acceptance of construct validation as an ongoing process rather than a singular outcome from any one investigation (American Educational Research Association, 1999; Strauss & Smith, 2009) .
The aims of this study apply select aspects of construct validation using a multitrait-monomethod approach. This approach allows the evaluation of convergent and divergent validity of the PHQ-9 and BDI-II on the basis of multiple trait (i.e., construct) comparisons with each other and theoretically distinct constructs (perceived stress, using the Perceived Stress Scale [PSS], and anxiety, using the Beck Anxiety Inventory [BAI] ). This approach does not, however, examine constructs across methods, which require data be collected in different formats (e.g., written selfreport, telephone interview). In the RCT from which data were collected, measures were completed in a self-report, written questionnaire format across study participants, precluding multimethod comparisons. In addition to adhering to traditional aspects of construct validity, the analyses focuses ''inward'' by examining not only the variance shared between measures of theoretically similar constructs (i.e., the convergence of the PHQ-9 and the BDI-II) but also the variance that is not shared. On the basis of reported correlations between the PHQ-9 and the BDI-II of r = .76 to .84, there remains a moderate amount of variance unaccounted for (1 j r 2 , or 29%Y43%). We wanted to further examine whether the within-subject similarity of scores differed across women on the basis of select characteristics. That is, within a sample of low-income women, we wanted to evaluate whether there are select characteristics that would explain why some women had remarkably similar levels of depressive symptom severity on the basis of BDI-II and PHQ-9 scores, whereas others had very different scores on these two measures. Finally, from a clinical perspective, cutoff criteria for different categories of depressive symptomatology on the basis of PHQ-9 and BDI-II scores are used often to guide further evaluation and treatment decisions, and it would be clinically useful to know whether women would be similarly classified on each measure on the basis of their severity score (e.g., on the basis of ''mild,'' ''moderate,'' etc., cutoff criteria specified within each instrument).
Methods

Sample
Participants in this study included 308 low-income women enrolled in an ongoing RCT to address health disparities among women receiving public assistance benefits through the Temporary Assistance for Needy Families (TANF) program. The study was approved by the university Health Science Center institutional review board. Women met eligibility criteria for enrollment in the ongoing study if they were receiving TANF benefits, between 18 and 60 years of age, not currently employed, not receiving disability benefits, not pregnant, could read and speak English, and had at least one chronic health condition. Chronic health conditions were defined broadly and included conditions ranging from relatively self-limiting problems such as seasonal allergies to more severe chronic health conditions such as diabetes, hypertension, or other forms of cardiovascular disease. Conditions were identified by self-report during an extensive physical and mental health assessment using a battery of standardized, valid, and reliable, selfadministered health and health-related measures, including the BDI-II and the PHQ-9. Data for these analyses were collected between February 27, 2006, and September 24, 2008 , were collected at the study enrollment visit, and represent baseline values unaffected by the RCT intervention.
Measures
As noted, demographic and other variables were measured by self-report. In addition to select demographic and health variables, data were collected using self-report that are directly relevant to the analyses presented hereVincluding perceived stress, general health, anxiety, and the number of chronic health conditions.
Perceived stress was measured using the 14-item PSS (Cohen, Tyrrell, & Smith, 1993) . It has documented validity and reliability (testYretest correlation coefficients of r = .85 and Cronbach alphas of .79Y.86) in low-income populations (Kneipp et al., 2009; Tuck & Wallace, 2000) . Scores range from 0 to 56, with higher scores indicating higher levels of stress. General health was measured using the Short Form-12 Version 2.0 (SF-12v2; Ware, Kosinski, Turner-Bowker, & Gandek, 2002) . The SF-12v2 is based on the SF-36, which has been used extensively in diverse populations. The SF-12v2 provides summary scores for physical and mental health that have demonstrated validity and reliability (! 9 .80; testYretest coefficients = .78 and .60, respectively) and predicts 990% of the variance in SF-36 summary scores. The SF-12v2 captures eight health dimen-sionsVone being general health, which was used to measure general health in this study. Anxiety was measured using the 21-item BAI. The BAI has a score range of 0 to 63, has demonstrated validity and reliability (! 9 .90, testYretest coefficient = .75), and has been used in diverse populations (Beck & Steer, 1990) . Finally, participants provided a self-report of the number of chronic health conditions and were instructed to base their responses on the number of health problems that had been diagnosed by a health care provider.
Data Analysis
Analyses were conducted using Stata/SE Version 10.0 and SAS Version 9.1.3 statistical software.
Missing Data Of the 308 women enrolled, not more than 11% had missing data on the BDI-II, PHQ-9, PSS, or BAI. Missing data were at the item level, meaning participants were missing data on select items or questions, within a particular instrument, as opposed to not having answered any of the questions on a given measure. Among the relatively small proportion with missing data, the vast majority (988%) had two items or less missing on any one instrument. There were no differences in participants with respect to age, race, marital status, number of children, or number of chronic conditions by complete versus incomplete data, which suggests data were missing at random (Little & Rubin, 2002) . Using a multinomial logistic regression prediction model (Horton & Laird, 2001) , missing data were imputed at the item level. Predictor selection for imputing missing items within each measure was based on the distribution of the construct measured by select demographics and other health-related measures or nonmissing items in the instrument with which it correlated most strongly and consistently over time (Kneipp et al., 2009) . A consistent imputation model was applied to impute items within instruments; so, for example, when age, race, and number of chronic health conditions were highly correlated with the measure in which items were being imputed, these same predictors were consistently included in the imputation model for every missing item within the same measure to both reduce variability and to avoid introducing bias in the imputed items.
Convergent and Divergent Validity Symptom severity scores included the sum of all 21 items in the BDI-II and Items 1 through 9 on the PHQ-9 using standard scoring procedures for each (Beck et al., 1996 ; The John D. & Catherine T. MacArthur Foundation's Initiative on Depression & Primary Care, 2004). On the basis of our prior confirmatory factor analysis findings, which indicate that the BDI-II in this population is comprised of a complex factor structure that includes general depression (i.e., the full-scale, standard BDI-II that includes all 21 items), cognitive (subscale), and somatic (subscale) domains (Kneipp et al., 2009 ), these were included in the multitrait-monomethod analysis. Given the skewed distribution of the BDI-II domain scores and the PHQ-9 symptom severity scores (ShapiroYWilk test for normality, p G .001), Spearman's rho was used to evaluate convergent and divergent validity using a multitrait-monomethod approach.
Differences in Standardized BDI-II and PHQ-9 Scores The BDI-II and the PHQ-9 have very different possible symptom severity score ranges (0Y63 and 0Y27, respectively). To meaningfully examine difference scores between symptom severity findings within subjects, scores for each instrument were standardized to z scores with mean values of zero and standard deviations of one. Standardizing variables in this way allowed for a direct comparison of scores and the calculation of difference scores in the BDI-II and PHQ-9 within subjects. Difference scores were calculated by subtracting the standardized BDI-II score from the standardized PHQ-9 score.
A stepwise, backward elimination approach was used to regress the standardized BDI-II/PHQ-9 difference score (Std_PBDiff) on select predictors, given the exploratory nature of the inquiry and the lack of a comprehensive or co-hesive theory to more specifically guide model building (Hair, Black, Babin, & Anderson, 2005) . Demographic variables that tend to consistently relate to a wide variety of health outcomes (i.e., age, race, and education), factors that could reasonably be expected to account for differences in depression measure scores on the basis of theoretical and measurement construct considerations (i.e., a history of depression, number of chronic conditions, and the total number of mental and physical symptoms experienced), and variables that have been associated strongly with depressive symptoms in prior studies with the same population (i.e., perceived stress) (Kneipp, Welch, Wood, Yucha, & Yarandi, 2007) were included in the full, initial regression model (Little & Rubin, 2002) .
With the standardized BDI-II/PHQ-9 difference score (Std_PBDiff) as the dependent variable, data were examined using standard procedures to assure multiple regression assumptions could be met and to determine whether influential cases were present. The assumptions of normality, linearity, and independence were met (Meyers, Gamst, & Guarino, 2006) . Three outliers were identified to be highly influential on the basis of regression diagnostic plots, which included studentized residuals of +3/j3, leverage 9 (2k + 2) / n (k = number of predictors), a DFITS values 9 2¾(k/n), and DFBETA values 9 2¾(n). The primary concern with outliers was their influence on regression beta coefficients. Highly influential outliers were identified by examining both DFITS and DFBETA values in Stata/SE 10.0, which are considered composite indicators of outlier status and leverage. Both provide a measure of the difference between the regression coefficient when the ith observation is included and excluded in the model, albeit on different scales (StataCorp, 2007) . On the basis of a comprehensive examination of regression diagnostics findings, these outliers were likely to have undue influence on regression coefficients for the majority of predictors included in the model. Importantly, the decision was made to remove these outliers from the regression analyses a priori (before running the final regression model) and without examining whether the regression findings were similar or different with the outliers ''in'' or ''out'' of the model. In so doing, the intent was to make sound analytic decisions on the basis of standard regression diagnostic approaches (Belsley, Kuh, & Welsch, 2004) and to avoid the introduction of bias that can occur when different findings from different models (i.e., ''with'' and ''without'' outliers) are comparedVand a final analytic approach is selectedV a posteriori. Once these three outliers were removed, there were no additional extreme influential cases.
BDI-II and PHQ-9 Symptom Severity Classification Both the BDI-II and the PHQ-9 use a set of cutoff scores to classify levels of depressive symptoms that range from ''minimal'' to ''severe'' (Arnau, Meagher, Norris, & Bramson, 2001; Kroenke et al., 2001) . However, the BDI-II reflects four levels of symptom severity while the PHQ-9 includes five levels (the addition of a ''moderateYsevere'' category), preventing direct classification comparisons between instruments.
Because of the clinical significance of the depressive classification categories, we wanted to examine whether a trend association of symptom severity classification between the BDI-II and the PHQ-9 was presentVthat is, as the level of BDI-II classification increased, did the level of classification similarly increase on the PHQ-9 schema? To examine this question, the MantelYHaenszel test for linear association was applied (Mantel, 1963) , which takes advantage of the ordered categorical classifications to test for a linear trend between the depression classification schemes. Symptom classifications were based on the raw (i.e., the continuous, nonYz score transformed) symptom severity summary scores as outlined in the scoring manuals for each measure (Beck et al., 1996 ; The John D. & Catherine T. MacArthur Foundation_s Initiative on Depression & Primary Care, 2004). A component of the MantelYHaenszel test is the choice of scores to use for the within measure categories. Although different choices usually have little effect on the results, sometimes an imbalance in category frequency can lead to different conclusions. We followed the advice of Agresti (2002) and performed a sensitivity analysis by running the results with two reasonable approaches to score selectionVequally spaced and standardized midranksVand compared the results.
Results
Sample Demographics
Study participants were predominantly Black/African American (55.6%) and unmarried (90.6%), averaged 29.5 years of age, had an average of 2.4 children, and lived on less than $600 per month (including cash assistance from TANF, food stamps, and any other cash received). Over one third had less than a 12th-grade education (35%), with another third (33%) reporting some college or technical training. The mean number of chronic conditions reported was 2.6; depressive symptom severity scores were 19.6 (SD = 12.2) for the BDI-II and 10.6 (SD = 6.5) for the PHQ-9. Sample demographics are detailed in Table 1 .
Convergent and Divergent Validity
Examination of the multitrait-monomethod matrix ( Table 2) demonstrates convergent validity and some evidence for divergent validity given the pattern of correlations between constructs. As expected, the correlation coefficient for the BDI-II General Depression domain and the PHQ-9 on the basis of Spearman's rho (r s ) was high, at .80 (p G .001). Although the BDI-II General Depression and the BDI-II Cognitive domains were most highly correlated (.91, p G .001), this was not surprising, given the BDI-II General Depression score is comprised in part by the Cognitive and Somatic domain items. Notably, the BDI-II General Depression domain and the PHQ-9 were more highly correlated than either of these constructs were with the PSS or the BAI, and the BDI-II General Depression domain correlated more highly with the PHQ-9 than either the BDI-II Cognitive or the Somatic subscale domains. These findings suggest that, among the multiple traits examined, the standard BDI-II (General Depression) and the PHQ-9 demonstrate a fairly high degree of convergent validity. There was some support for divergent validity as well because correlations between the two depression measures and the PSS and BAIVwhich were not intended to measure depressive symptomsVwere lower (ranging from .60 to .69) than those observed between the BDI-II and PHQ-9 (r s = .80).
Predictors of BDI-II and PHQ-9 Score Differences
After z score standardization and the removal of the three outliers, mean BDI-II and PHQ-9 scores were j0.014 (SD = 0.99) and j0.005 (SD = 1.00), respectively. Differences in within-person standardized BDI-II and PHQ-9 scores ranged from j1.78 to 1.76, with negative difference scores indicating that the BDI-II standardized score was higher than the PHQ-9 standardized score and positive difference scores indicating that the PHQ-9 standardized score was higher than the BDI-II standardized score. Findings from the backward stepwise regression are detailed in Table 3 . Each predictor included in a model was tested by itself (a single degree of freedom test) with the exception of race, which was tested in each model using a two degree of freedom test of overall race effect for Black/African American or Other. Predictors with the least significance were dropped one by one from the model in the following order: age (p = .90), anxiety (p = .87), number of chronic health conditions (p = .88), number of symptoms (p = .34), depression history (p = .29), race (p = .23), and education level (p = .08). This model q reduction approach resulted in perceived stress as the final remaining predictor, although this was also not statistically significant (p = .08). In addition to the lack of statistically significant predictors, the amount of variance explained by the full model and thus each reduced model did not exceed 3.7%, indicating no subset of predictors explained the within-person differences between standardized BDI-II and PHQ-9 symptom severity scores. q BDI-II and PHQ-9 Symptom Severity Classification Frequencies for symptom severity categories of the BDI-II and PHQ-9 are shown in Table 4 . Overall, on the basis of the category distributions, the PHQ-9 seems to be concentrated more in the middle categories, with the highest two being mild (26%) and moderate (27%). In contrast, the BDI-II scores seemed to be distributed more in the extremes with the highest two categories being none/minimal (35%) and severe (24%). In order to test the question of whether a significant trend exists on the basis of the categorical designations, we used the MantelYHaenszel test for linear association. The tests performed with equally spaced scoring and standardized ranks yielded little difference. With equal spacing, the chi-square equaled 172.6 (p G .0001), and with standardized midranks, the chi-square equaled 172.0 (p G .0001). This is evidence that there is a significant correlation between the categorical designations of the two depressive scoring systems. That is, individuals falling into higher categories in one instrument would tend to rate higher in the other and vice versa.
Discussion
The BDI-II and the PHQ-9 are highly regarded measures of depressive symptoms with well-documented validity and reliability for use in both research and clinical settings. For screening purposes, both have acceptable predictive values when compared to the Structured Clinical Interview for DSM -Depression, which is considered a gold standard for diagnosing depression (Watnick et al., 2005) . For research purposes, each is commonly used to measure depressive symptom severity. In terms of construct validity, the PHQ-9 has consistently demonstrated a one-factor structure consistently across studies with diverse patient and nonpatient groups (Dum et al., 2008; Hepner et al., 2009; Huang et al., 2006) . The BDI-II has demonstrated less consistency in factor structure across studies, and more recent analyses suggest that its factor structure is a complex, higher ordered structure in both low-income women (Kneipp et al., 2009) and other populations with varying health conditions (Thombs et al., 2008) . Our finding of high convergent validity of BDI-II and PHQ-9 symptom severity scores in this population (r s = .80) similarly parallels prior findings in the literature, which range from 0.76 to 0.84 (Dbouk et al., 2008; Dum et al., 2008; Hepner et al., 2009) . In terms of convergent validity, correlation coefficients within the range typically found between the BDI-II and the PHQ-9 clearly indicate that there is theoretical and/or construct similarity between the constructs being measured; yet, there remains some unaccounted for varianceVin this study, for example, 46%Vin the within-person scores between these measures.
The major findings of this study were in demonstrating parallel support for the construct validity of the BDI-II and the PHQ-9 with low-income women. The parallel validation evidence included those findings supporting convergent and divergent validity on the basis of the multitrait-monomethod matrix analyses and the strong relationship of the classification systems. The inability to explain within-person differences in standardized scores between the BDI-II and PHQ-9 on the basis of a number of demographic and other health characteristics among low-income women also suggests the parallel interpretations of the two instruments that is specific to this population. This latter finding makes a unique contribution to the existing literature by discerning the extent to which the PHQ-9 can be used in place of the BDI-II in studies with low-income women when the goal is to measure depressive symptom severity. More specifically, this finding suggests that differences in the within-subject BDI-II and PHQ-9 symptom severity scores appear to be unrelated to salient, and potentially confounding, demographic, psychosocial, and health factors examined here.
Overall, our findings should instill some degree of confidence that these two instruments can be used interchangeably as measures of depressive symptom severity for many studies with samples similar to ours, suggesting that factors other than validity concerns may be used to select between the two instruments. For example, the PHQ-9 is available to the public at no cost, involves less respondent burden than the BDI-II, and scores more easily in clinical settings; as such, the PHQ-9 may have distinct advantages over the BDI-II in circumstances in which financial constraints, respondent burden, or time pressures at data collection occasions are concerns. There is a more recently developed version of the BDIVthe BDI-Fast ScreenVwhich can be administered in a short period of time (Beck, Steer, & Brown, 2000) . However, while the BDI-Fast Screen has demonstrated good sensitivity and specificity in a pain clinic population (Poole, Bramwell, & Murphy, 2009 ), it has had less q The MantelYHaenszel test for linear association with equally spaced and standardized midranks scoring: # 2 = 172.6 and 172.0, respectively, df = 1, p G .0001.
predictive value among older stroke patients (Healey, Kneebone, Carroll, & Anderson, 2008) , and testing in other populations is limited. Other factors should drive decision making around the adoption of one measure over another. For example, the BDI-II may be preferred in studies with subjects for whom suicidal intent/plan is a concern because the BDI-II more directly assesses a more ''active'' or ''direct'' form of suicidal ideation (e.g., references to ''killing myself''), whereas the PHQ-9 assesses a more ''passive'' form of suicidal ideation (e.g., a reference to ''[thoughts of] being better off dead or of hurting yourself in some way''). Finally, between the two measures examined here, the PHQ-9 may have less potential confounding of general, depression-related somatic symptoms with those that coexist with other disease states (e.g., fatigue after a myocardial infarction) (Thombs et al., 2008) , given that proportionally fewer PHQ-9 items assess somatic symptoms of depression compared with the BDI-II (Kneipp et al., 2009 ). These and other additional considerations may be more or less important in the measurement selection process depending on the specific aims and unique qualities of any given study.
There are, of course, limitations of this study and its findings that should be noted. First, 11% of the sample had missing data. Although missing data were minimal, apparently random, and able to be corrected with accepted imputation procedures, this remains a study limitation. Second, these findings are not generalizable beyond women who are low-income Caucasian or African American/Black and who have at least one identified chronic health condition (as defined broadly within our sample). Third, although we included predictors of BDI-II and PHQ-9 within-person score differences on the basis of prior findings and theoretical considerations, the set of predictors included was clearly not exhaustive, and the possibility remains that a relevant predictor of these differences was not accounted for in our regression models.
Overall, these findings provide investigators interested in depression among low-income women additional data upon which to base measurement selection decisions. For researchers seeking a measure of depressive symptoms, these findings demonstrate that the BDI-II and the PHQ-9 perform similarly in this population. These findings make an important contribution to the measurement literature to advance health disparities research. q Accepted for publication August 16, 2010.
